• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic study of amobarbital elimination based on its kinetics in twins.

作者信息

Endrenyi L, Inaba T, Kalow W

出版信息

Clin Pharmacol Ther. 1976 Dec;20(6):701-14. doi: 10.1002/cpt1976206701.

DOI:10.1002/cpt1976206701
PMID:1033050
Abstract

Following the intravenous administration of 125 mg amobarbital sodium in 7 pairs of dizygotic and 7 pairs of monozygotic twins, the time-course of plasma concentrations was observed. The number of detectable compartments varied from subject to subject but was consistently 1 or 2 or 3 within a given individual. The terminal slope of the semilogarithmic concentration-time plot (corresponding to biologic half-life of 22.8 hr) did not represent the elimination rate constant even in persons with apparently single-compartmental characteristics. The redistribution of amobarbital was rapid in comparison with its elimination. The rate of the latter (characterized by kel = 0.051 hr-1, plasma clearance = 37.7 ml/min) could be closely identified with the rate of metabolism. The twin data showed that genetic control was exerted on kinetic parameters characterizing the rate of amobarbital elimination and, therfore, the rate of its metabolism. Correlation analysis suggested that this control was independent of size factors, which were themselves substantially heritable. The genetic analysis of twin data included, in addition to intracelass correlations and Holzinger's H factors, newly developed lower (and upper) bounds of the broad-sense heritability. In pharmacogenetic studies, assessment of model-independent kinetic parameters, such as plasma clearance with or without adjustment for body weight, is recommended.

摘要

相似文献

1
Genetic study of amobarbital elimination based on its kinetics in twins.
Clin Pharmacol Ther. 1976 Dec;20(6):701-14. doi: 10.1002/cpt1976206701.
2
Theophylline metabolism: variation and genetics.茶碱代谢:变异与遗传学
Clin Pharmacol Ther. 1984 Feb;35(2):170-82. doi: 10.1038/clpt.1984.23.
3
Clinical pharmacology of antidepressant drugs: pharmacogenetics.抗抑郁药物的临床药理学:药物遗传学
Adv Biochem Psychopharmacol. 1984;39:359-72.
4
Polymorphism of theophylline metabolism in man.人体中茶碱代谢的多态性。
J Clin Invest. 1985 May;75(5):1415-25. doi: 10.1172/JCI111843.
5
Sources of interindividual variations in acetaminophen and antipyrine metabolism.对乙酰氨基酚和安替比林代谢个体间差异的来源。
Clin Pharmacol Ther. 1984 Oct;36(4):417-30. doi: 10.1038/clpt.1984.199.
6
Inheritance of hypodontia in twins.双胞胎中缺牙症的遗传情况。
Coll Antropol. 1998 Jun;22(1):291-8.
7
Biliary lipid composition in monozygotic and dizygotic pairs of twins.单卵双胞胎和双卵双胞胎对的胆汁脂质成分。
Gut. 1989 Dec;30(12):1750-6. doi: 10.1136/gut.30.12.1750.
8
Lifestyle factors in monozygotic and dizygotic twins.同卵双胞胎和异卵双胞胎中的生活方式因素。
Genet Epidemiol. 1988;5(5):311-21. doi: 10.1002/gepi.1370050503.
9
Comparative drug elimination in man-diphenylhydantoin and amobarbital.人体内苯妥英钠和异戊巴比妥的药物消除比较
Eur J Clin Pharmacol. 1975 Oct 10;9(1):79-83. doi: 10.1007/BF00613433.
10
The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects.双胞胎中乙醇吸收与消除的动力学以及在单胎受试者中的补充重复实验。
Eur J Clin Pharmacol. 1977;11(5):337-44. doi: 10.1007/BF00566530.

引用本文的文献

1
BIOMARKERS AND NEUROBEHAVIORAL DIAGNOSIS.生物标志物与神经行为诊断
Biomark Neuropsychiatry. 2021 Jun;4. doi: 10.1016/j.bionps.2020.100029. Epub 2021 Jan 4.
2
Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).伯纳德·勒勒:2014年首届全球组学与个性化医学沃纳·卡洛负责任创新奖获得者(环太平洋临床药物遗传学协会)
OMICS. 2014 Apr;18(4):211-21. doi: 10.1089/omi.2014.0029. Epub 2014 Mar 20.
3
Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins.
安替比林代谢产物形成速率的基因变异:一项针对未诱导双胞胎的研究。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5193-6. doi: 10.1073/pnas.78.8.5193.
4
Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.安替比林代谢产物形成变异的单基因控制。肝脏药物氧化的新多态性。
J Clin Invest. 1983 Jun;71(6):1698-709. doi: 10.1172/jci110924.
5
[Perdormal kinetics].[Perfomal动力学] (你提供的原文中“Perdormal”可能有误,推测可能是“Perfomal”,具体需结合完整内容判断)
Z Rechtsmed. 1983;89(4):243-6. doi: 10.1007/BF00203728.
6
Ethnic differences in drug metabolism.药物代谢中的种族差异。
Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400. doi: 10.2165/00003088-198207050-00001.
7
Assessment of methods to identify sources of interindividual pharmacokinetic variations.个体间药代动力学差异来源识别方法的评估
Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002.
8
Enzyme induction following a single dose of amobarbital in dogs.犬单次服用异戊巴比妥后的酶诱导作用。
J Pharmacokinet Biopharm. 1978 Aug;6(4):305-13. doi: 10.1007/BF01060094.
9
Individual differences in the disposition of drugs metabolised in the body.
Clin Pharmacokinet. 1978 Mar-Apr;3(2):155-75. doi: 10.2165/00003088-197803020-00005.
10
Clinical pharmacokinetics of hypnotics.催眠药的临床药代动力学。
Clin Pharmacokinet. 1977 Mar-Apr;2(2):93-109. doi: 10.2165/00003088-197702020-00002.